FDA Charts Transparency Plans | GenomeWeb

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Food and Drug Administration has issued a report detailing its plans to enhance the agency’s transparency and communications efforts to the industries it regulates, which include the recent launch of a website to provide companies with submission and regulatory information, and it is seeking public comments on some of these plans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.